EUVIMEDEUVIMED entdecken
Crossref

Dexamethasone activates c-Jun NH2-terminal kinase (JNK) which interacts with GR and protects it from ubiquitin-mediated degradation in NSCLC cells

Swati Srivastava, Shumaila Siddiqui, Sangita Chowdhury, Arun Kumar Trivedi

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.01.079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Swati Srivastava und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Biology, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, UP, India. Electron…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Council of Scientific & Industrial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dexamethasone-mediated pharmacological activation of the glucocorticoid receptor (GR) is widely used in the treatment regimen of hematological malignancies and solid cancers. However, DEX sensitivity towards patients primarily depends on the endogenous protein levels of GR. We observed that DEX treatment leads to an increase in GR protein levels despite inhibition of neo-protein synthesis in non-small cell lung cancer (NSCLC) cells. Mechanistically, DEX-stimulation concomitantly increased the JNK phosphorylation and GR protein levels, however the JNK stimulation preceds GR upregulation. Moreover, we also observed that DEX-mediated phosphorylation is partially mediated by upregulation in MEKK1 phosphorylation. Further, GR protein levels were significantly decreased in JNK inhibitor (JNKi, SP600125) treated cells whereas MG132 treatment restored GR levels indicating that DEX induced JNK activity regulated the GR protein levels through proteasomal-degradation pathway. Next, we showed that DEX led to JNK activation which physically interacts with GR and protects it from ubiquitination-mediated degradation. Furthermore, at basal level GR interacts with JNK in cytoplasm whereas upon DEX stimulation GR and pJNK both localized to nucleus and interact with each other. Next, we show that JNK-mediated GR stabilization affects its nuclear transcriptional functional activity in NSCLC cells. In line with these in vitro data, patient dataset analysis also shows that increased levels of both JNK and GR contributes towards better prognosis of NSCLC patients. Taken together, our data shows that DEX treatment may lead to positive feedback regulation of GR by activating JNK and thus highlights importance of GR-JNK crosstalk in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansReceptors, GlucocorticoidJNK Mitogen-Activated Protein KinasesDexamethasoneUbiquitinGlucocorticoids

Stichwörter der Autor:innen

ChemotherapyDexamethasoneGlucocorticoid receptorJNK pathwayUbiquitination

Substanzen

Receptors, GlucocorticoidJNK Mitogen-Activated Protein KinasesDexamethasoneUbiquitinGlucocorticoids

Autor:innen und Institutionen

  • Division of Cancer Biology, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, UP, India. Electronic address: swatisatb1@gmail.com.
  • Division of Cancer Biology, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, Indi…
  • Division of Cancer Biology, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, UP, India.

Förderung

  • Council of Scientific & Industrial Research

Zitieren

APA

Srivastava, S., Siddiqui, S., Chowdhury, S., & Trivedi, A. K. (2023). Dexamethasone activates c-Jun NH2-terminal kinase (JNK) which interacts with GR and protects it from ubiquitin-mediated degradation in NSCLC cells. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.01.079

Vancouver

Srivastava S, Siddiqui S, Chowdhury S, Trivedi AK. Dexamethasone activates c-Jun NH2-terminal kinase (JNK) which interacts with GR and protects it from ubiquitin-mediated degradation in NSCLC cells. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.01.079

BibTeX
@article{Srivastava2023,
  author = {Srivastava, Swati and Siddiqui, Shumaila and Chowdhury, Sangita and Trivedi, Arun Kumar},
  title = {Dexamethasone activates c-Jun NH2-terminal kinase (JNK) which interacts with GR and protects it from ubiquitin-mediated degradation in NSCLC cells},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.01.079}
}
Kostenlos starten →